KLARESPON

Serial Number 86268592
606

Registration Progress

Application Filed
May 1, 2014
Under Examination
May 19, 2015
Approved for Publication
Mar 24, 2015
Published for Opposition
Mar 24, 2015
Registered

Basic Information

Serial Number
86268592
Filing Date
May 1, 2014
Published for Opposition
March 24, 2015
Abandonment Date
June 20, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 20, 2016
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Brian T. Jaenicke

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

22 events
Date Code Type Description
Jun 20, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jun 20, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 21, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 19, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 19, 2015 EXT1 S SOU EXTENSION 1 FILED
Oct 19, 2015 EX1G S SOU EXTENSION 1 GRANTED
May 19, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 24, 2015 PUBO A PUBLISHED FOR OPPOSITION
Mar 24, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2015 ALIE A ASSIGNED TO LIE
Jan 27, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 5, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2014 CNRT R NON-FINAL ACTION WRITTEN
Jul 31, 2014 GNRT F NON-FINAL ACTION E-MAILED
Jul 31, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 25, 2014 DOCK D ASSIGNED TO EXAMINER
May 15, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005